BALTIMORE, Sept. 10, 2019 /PRNewswire/ -- Capsulomics CEO and co-founder Daniel Lunz presented the company's groundbreaking development: DNA tests for the early

NEW YORK, Sept. 10, 2019 /PRNewswire/ -- Kindbody, a women's health and technology company, today unveiled its flagship clinic in New York City's Flatiron distric

NEW YORK, Sept. 10, 2019 /PRNewswire/ -- The New York Proton Center, the first proton therapy facility to open in New York State, has begun treating patients. The center's unique consortium of partners, comprised of three leading New York City health systems—Memorial Sloan Kettering Cancer Center (MS

DENVER, Sept. 10, 2019 /PRNewswire/ -- Diego Pellicer Worldwide, Inc. (OTCQB: DPWW), the premium marijuana brand and development company, today announced that it has executed a letter of intent to purchase a cannabis cultivation facility in Denver. The 13,000 square-foot cultivation facility produces approximately 2,000 pounds of can

PALO ALTO, Calif., Sept. 10, 2019 /PRNewswire/ -- The New York Proton Center (NYPC) has treated its first proton therapy cancer patients. Equipped with the Varian ProBeam® proton therapy system, NYPC is New York State's first proton therapy facility and is a collaboration between Memorial Sloan Kettering Cancer Center, Mont

DURHAM, N.C., Sept. 10, 2019 /PRNewswire/ -- MindPath Care Centers, the state's largest outpatient mental and behavioral healthcare provider, is pleased to announce sponsorship of Evening of Hope, the annual charity dinner and auction benefiting The Foundation of Hope for Research & Treatment of Mental Illness. The event will take place

SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ -- Karuna Labs, creator of personalized functional restoration and chronic pain management programs using Virtual Rea

WHIPPANY, N.J., Sept. 10, 2019 /PRNewswire/ -- Each year, U.S. News & World Report collaborates with Pharmacy Times to ask thousands of pharmacists: which over-the-counter (OTC) products do you recommend the most?

HADDONFIELD, N.J., Sept. 10, 2019 /PRNewswire/ -- Linnaeus Therapeutics, Inc. ("Linnaeus"), a privately held biopharmaceutical company focused on the development and commercialization of novel, small molecule oncology therapeutics, today announced that its scientific cofounder, Todd Ridky, MD, PhD, Assistant Professor of Dermatology at

SAN DIEGO, Sept. 10, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in